| ID | Sequence | Length | GC content |
|---|---|---|---|
| AUCACUUGCCCCACAGAUACCCUCGUGAUUAGAGGUCUUUUGCUGGAGG… | 6042 nt | 0.5003 | |
| AUCACUUGCCCCACAGAUACCCUCGUGAUUAGAGGUCUUUUGCUGGAGG… | 3197 nt | 0.4636 | |
| GUAGCUAUAGCAGCCGCGGCGGUUAAGUAUGCGGCGCCAGGAGCUCUCU… | 6143 nt | 0.4986 | |
| GUAGCUAUAGCAGCCGCGGCGGUUAAGUAUGCGGCGCCAGGAGCUCUCU… | 6723 nt | 0.4920 | |
| AGACCUGCUCUAGACGCUGACUGAAUGUUUUCCUAGUUCCAAGUCCUGC… | 6768 nt | 0.4911 | |
| AUCACUUGCCCCACAGAUACCCUCGUGAUUAGAGGUCUUUUGCUGGAGG… | 6057 nt | 0.5004 | |
| GUAGCUAUAGCAGCCGCGGCGGUUAAGUAUGCGGCGCCAGGAGCUCUCU… | 6960 nt | 0.4927 | |
| GUAGCUAUAGCAGCCGCGGCGGUUAAGUAUGCGGCGCCAGGAGCUGCUA… | 5917 nt | 0.5013 | |
| GUAGCUAUAGCAGCCGCGGCGGUUAAGUAUGCGGCGCCAGGAGCUCUCU… | 6601 nt | 0.4949 | |
| GUAGCUAUAGCAGCCGCGGCGGUUAAGUAUGCGGCGCCAGGAGCUCUCU… | 6263 nt | 0.4986 |
Enables K63-linked deubiquitinase activity and cysteine-type deubiquitinase activity. Predicted to be involved in protein deubiquitination and proteolysis. [provided by Alliance of Genome Resources, Jul 2025]
A study in human body fluids using a custom MPS primer panel demonstrated that the USP54 was included in a refined primer panel (V4) for time since deposition estimation [Hänggi et al. DOI:10.1016/j.fsigen.2025.103415].